| Literature DB >> 24330393 |
Ken-ichi Yoshida1, Yuki Takemoto, Takayuki Sotsuka, Kosei Tanaka, Shinji Takenaka.
Abstract
BACKGROUND: Bradyrhizobium japonicum USDA110, a soybean symbiont, is capable of accumulating a large amount of poly-β-hydroxybutyrate (PHB) as an intracellular carbon storage polymer during free-living growth. Within the genome of USDA110, there are a number of genes annotated as paralogs of proteins involved in PHB metabolism, including its biosynthesis, degradation, and stabilization of its granules. They include two phbA paralogs encoding 3-ketoacyl-CoA thiolase, two phbB paralogs encoding acetoacetylCoA reductase, five phbC paralogs encoding PHB synthase, two phaZ paralogs encoding PHB depolymerase, at least four phaP phasin paralogs for stabilization of PHB granules, and one phaR encoding a putative transcriptional repressor to control phaP expression.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24330393 PMCID: PMC4029623 DOI: 10.1186/1471-2180-13-290
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Figure 1Similarities among the gene products putatively involved in PHB polymerization/depolymerization. Similarities were calculated using the FASTA program [26] for each of the indicated pairs. FASTA optimized scores (boldface) and sequence identity (percentage/overlapping amino acid residues) are shown. Size, given as the number of amino acid residues, is indicated beneath the product name.
Figure 2Alignment of amino acid sequences of predicted PhaP phasins. White letters on a black background and boxed letters designate conserved and equivalent residues, respectively. The alanine-rich sequence in the C-terminus is underlined beneath the sequence of PhaP4.
Figure 3Growth and PHB accumulation of USDA110. (A) Growth curves for B. japonicum USDA110 cells grown in YEM (solid squares), TY (solid circles), and PSY (solid triangles) media. (B) Amounts of PHB accumulated. Values are means of three independent results ± SD. ND: not detected.
Figure 4Transcription profile of the genes deduced to be involved in PHB metabolism and accumulation. (A) Expression of the genes for PHB biosynthesis and degradation. qRT-PCR analysis was performed as described in the Methods, and data were normalized to constitutively expressed sigA as an internal control. Values are means of three independent results ± SD, and those followed by the same letters are not significantly different at the 95% confidence level. ND: no specific PCR product was detected as in the negative control experiment without reverse transcription, and thus was not taken into account for statistic analysis. (B) Expression of the four PhaP phasins. qRT-PCR analysis was performed and the results are presented as described for (A).
Figure 5PHB binding of His-tag PhaP phasins and His-tag PhaR . (A) Immunoblots to detect proteins contained in PHB/protein complexes. The amounts of target protein in the crude extracts were compared to controls, and then fixed to contain the same concentration of each of the His6-tag fusions of four PhaP phasins and PhaR. Target proteins were mixed with serially diluted suspensions of PHB, as a fine powder, in test tubes and incubated to allow formation of PHB/protein complexes. The PHB/protein complexes were spun down, washed to remove non-specific proteins, and then subjected to 18% SDS-PAGE followed by the immunoblot analysis as described in the Methods. Total crude extract in a tube (lane 1) and proteins contained in the PHB/protein complexes formed without (lane 6) and with 1.500% (w/v) (lane 2), 0.375% (lane 3), 0.094% (lane 4), and 0.023% (lane 5) PHB are loaded. One set of representative data, from three independent experiments with similar results, is shown. (B) Summary of PHB binding assay. Signal intensities on the immunoblots were quantified using ImageJ software [29] and defined as the parameters representing the amounts of the His6-tag fusion proteins on the blots. The amounts of His6-tag fusions contained in the PHB/protein complexes, formed without (lane 6 in panel A) and with 1.500% (w/v) (lane 2), 0.375% (lane 3), 0.094% (lane 4), and 0.023% (lane 5) PHB, are expressed as percentages of total amounts of respective fusions (lane 1). Values are means of three independent results ± SD, and those followed by the same letters are not significantly different at the 95% confidence level.
Figure 6Competition in PHB binding between His-tag PhaP4 and His-tag PhaR. The amount of crude extract was compared to controls and fixed to contain His6-tag PhaR equivalent to 0.094% (w/v) PHB in each of the tubes, and then various amounts of extract containing His6-Tag PhaP4 were added and incubated to allow formation of PHB/protein complexes. The complexes were spun down and subjected to the immunoblot analysis described in Figure 5. Lane 1 contains His6-tag PhaR alone and no His6-tag PhaP4. Concentrations of His6-tag PhaR and His6-tag PhaP are controlled in the ratios of 4:1 (lane 2), 4:2 (lane 3), 4:4 (lane 4), 4:8 (lane 5), and 4:16 (lane 5). One set of representative data, from three independent experiments with similar results, is shown.
Bacterial strains and plasmids
| USDA110 | | 24 |
| DH5a | Laboratory stocks | |
| BL21 (DE3) | Laboratory stocks | |
| Plasmids | ||
| pET-28b | Protein expression vector, kanamycin resistant | Takara Bio |
| pETPhaP1 | pET28b carrying | This work |
| pETPhaP2 | pET28b carrying | This work |
| pETPhaP3 | pET28b carrying | This work |
| pETPhaR | pET28b carrying | This work |
| pColdII | Protein expression vector, ampicillin resistant | Takara Bio |
| pColdPhaP4 | pColdII carrying | This work |
Oligonucleotide primers
| PhaP1 NdeI | 5′- |
| PhaP1 XhoI | 5′- |
| PhaP2 NdeI | 5′- |
| PhaP2 XhoI | 5′- |
| PhaP3 NdeI | 5′- |
| PhaP3 XhoI | 5′- |
| PhaP4 NdeI | 5′- |
| PhaP4 HindIII | 5′- |
| PhaR NdeI | 5′- |
| PhaR HindIII | 5′- |
| RTphbA1-F | 5′-CATCGCCGTCAACAAGGA-3′ |
| RTphbA1-R | 5′-CCGCTTCTGCATCTCGAAC-3′ |
| RTphbA2-F | 5′-AAGAAGGCCGGCTGGAA-3′ |
| RTphbA2-R | 5′-CCATTGACGTTGACCTTGGA-3′ |
| RTphbB1-F | 5′-TCGAACTACGACGCCTGTG-3′ |
| RTphbB1-R | 5′-ATGCCGTCCTTGGTGATG-3′ |
| RTphbB2-F | 5′-CCGAAGGCGTGAAGAAGGT-3′ |
| RTphbB2-R | 5′-GAACAGCGAGCCGAGATTG-3′ |
| RTphbC1-F | 5′-GCTCTGGGAAAACATCTGGAAC-3′ |
| RTphbC1-R | 5′-TTGGTGATGGTGCGGAAA-3′ |
| RTphbC2-F | 5′-GGACGACTACGTTGAGGATGG-3′ |
| RTphbC2-R | 5′-AATGGCGAGTGCGGATG-3′ |
| RTphbC3-F | 5′-ATGACCGCGTCGAACCA-3′ |
| RTphbC3-R | 5′-GGCACCTTGACCTTGGAGA-3′ |
| RTphbC4-F | 5′-GGCGAAGACAGGCAAACA-3′ |
| RTphbC4-R | 5′-CTCCATCCATCCGAACCA-3′ |
| RTphbC5-F | 5′-CCGCAAAATTCCCTGGTC-3′ |
| RTphbC5-R | 5′-CATCCCTGTCCTTCGCATC-3′ |
| RTphaZ1-F | 5′-CCGAAGCAACGCACACA-3′ |
| RTphaZ1-R | 5′-ATCCTCGGCACGATTTCC-3′ |
| RTphaZ2-F | 5′-GGCACATCAAGCAGCACA-3′ |
| RTphaZ2-R | 5′-AGATCCATCACCGCGAAA-3′ |
| RTphaP1-F | 5′-ACGGCGACTACACCAAGAAG-3′ |
| RTphaP1-R | 5′-GAAGGTCTCGTAGGCGGAAC-3′ |
| RTphaP2-F | 5′-TCGCTTTTACCGAGCAGAAC-3′ |
| RTphaP2-R | 5′-GTGAACTGGCTACGCAGGA-3′ |
| RTphaP3-F | 5′-ATTACGGCACCAAGGTCATC-3′ |
| RTphaP3-R | 5′-GTGGAGAGGTTCACGAGGTC-3′ |
| RTphaP4-F | 5′-GTGCGACTGATCCATTCTCC-3′ |
| RTphaP4-R | 5′-GTCCTTGAACTTGGCGTAGC-3′ |
| RTphaR-F | 5′-CTTCGAGCAGGAGAACAAGG-3′ |
| RTphaR-R | 5′-GATATTTCGGCACCACCATC-3′ |
| RTsigA-F | 5′-CAGGCGAAGGACAAGGAAAA-3′ |
| RTsigA-R | 5′-CGTCGGACAGATCGAGCAA-3′ |